Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of Routine Oral Screening Programs for New Prisoners (DepiDent)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03736070
Recruitment Status : Recruiting
First Posted : November 8, 2018
Last Update Posted : April 18, 2019
Sponsor:
Collaborator:
General Health Office, France
Information provided by (Responsible Party):
University Hospital, Montpellier

Brief Summary:
In 2018, 10 detention centers in France will start organisational programs to improve the quality of screening of oral diseases, relatively to French recommendations, among new prisoners in France. Our study aims 1) to assess the prevalence and nosology of oral diseases ; 2) to describe the care pathway of participants during their stay in the detention center where they were included ; 3) to assess the cost of care per patient, from a societal perspective, using a top-down method.

Condition or disease
Oral Disease

Layout table for study information
Study Type : Observational
Estimated Enrollment : 1000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Assessment of Routine Oral Screening Programs for New Prisoners in France
Actual Study Start Date : March 1, 2018
Estimated Primary Completion Date : December 1, 2019
Estimated Study Completion Date : June 1, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Mouth Disorders




Primary Outcome Measures :
  1. Description of the oral problems of people entering detention [ Time Frame: 1 day ]
    Description of the oral problems of people entering detention : Any oral disease at inclusion (prevalence study)


Secondary Outcome Measures :
  1. attending to consultations [ Time Frame: The collection of data will end at the discharge of the participant, or at 6 months after inclusion. ]
    attending to consultations : The rate of attended visits is defined as the number of visits attended by the patient, divided by the number of scheduled visits, during the prison stay of the participant.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
New prisoners
Criteria

Inclusion criteria:

  • new prisoners
  • fluent French language

Exclusion criteria:

  • adult guardianship

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03736070


Contacts
Layout table for location contacts
Contact: Claire M DUFLOS, MD 467336407 ext 33 c-duflos@chu-montpellier.fr

Locations
Layout table for location information
France
Uhmontpellier Recruiting
Montpellier, France, 34295
Contact: Claire M DUFLOS, MD       c-duflos@chu-montpellier.fr   
Sponsors and Collaborators
University Hospital, Montpellier
General Health Office, France
Investigators
Layout table for investigator information
Principal Investigator: Claire M DUFLOS University Hospital, Montpellier

Layout table for additonal information
Responsible Party: University Hospital, Montpellier
ClinicalTrials.gov Identifier: NCT03736070     History of Changes
Other Study ID Numbers: RECHMPL18_0069
First Posted: November 8, 2018    Key Record Dates
Last Update Posted: April 18, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: NC

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Mouth Diseases
Stomatognathic Diseases